Joshua Yang
Chief Executive Officer at Glyphic Biotechnologies Inc
Joshua Yang active positions
| Companies | Position | Start | End |
|---|---|---|---|
Glyphic Biotechnologies Inc
 Glyphic Biotechnologies Inc Miscellaneous Commercial ServicesCommercial Services Glyphic Biotechnologies Inc is an American biotechnology company that develops a protein sequencing platform to provide researchers with new insights into biology and disease. Glyphic Biotechnologies was founded by Joshua Yang and Daniel Estandian, with Joshua Yang serving as the CEO since incorporation. | Chief Executive Officer | 31/12/2020 | - |
| Founder | 31/12/2020 | - | |
Cantos Ventures, LLC
 Cantos Ventures, LLC Investment ManagersFinance Cantos Ventures LLC (Cantos Ventures) is a venture capital firm founded in 2016 by Ian Rountree. The firm is headquartered in San Francisco, California. | Consultant / Advisor | - | - |
Nephrosant, Inc.
 Nephrosant, Inc. BiotechnologyHealth Technology Nephrosant, Inc. is a company dedicated to improving kidney health through noninvasive diagnostic tests. The company is based in Brisbane, CA. The company's flagship diagnostic test is QSant, a noninvasive urine-based test that supports early detection of kidney rejection risk. Nephrosant plans to develop centralized lab tests and point of care tests for kidney diseases and allograft monitoring for other organs. Founded in 2017 by Dr. Minnie Sarwal and UCSF physicians, the company has a team of world-class scientists, engineers, and clinicians who have licensed the founding team's clinical research to develop diagnostic tests for chronic kidney disease. Dr. Sarwal has been the CEO since 2017. | Founder | 31/12/2016 | - |
Career history of Joshua Yang
Training of Joshua Yang
| Stanford University | Graduate Degree |
| University of California San Diego | Undergraduate Degree |
| University of California | Graduate Degree |
| The Johns Hopkins University School of Medicine | Doctorate Degree |
| Johns Hopkins Berman Institute of Bioethics | Doctorate Degree |
Statistics
International
| United States | 9 |
Operational
| Founder | 2 |
| Graduate Degree | 2 |
| Doctorate Degree | 2 |
Sectoral
| Consumer Services | 6 |
| Finance | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Cantos Ventures, LLC
Cantos Ventures, LLC Investment ManagersFinance Cantos Ventures LLC (Cantos Ventures) is a venture capital firm founded in 2016 by Ian Rountree. The firm is headquartered in San Francisco, California. | Finance |
Nephrosant, Inc.
Nephrosant, Inc. BiotechnologyHealth Technology Nephrosant, Inc. is a company dedicated to improving kidney health through noninvasive diagnostic tests. The company is based in Brisbane, CA. The company's flagship diagnostic test is QSant, a noninvasive urine-based test that supports early detection of kidney rejection risk. Nephrosant plans to develop centralized lab tests and point of care tests for kidney diseases and allograft monitoring for other organs. Founded in 2017 by Dr. Minnie Sarwal and UCSF physicians, the company has a team of world-class scientists, engineers, and clinicians who have licensed the founding team's clinical research to develop diagnostic tests for chronic kidney disease. Dr. Sarwal has been the CEO since 2017. | Health Technology |
Glyphic Biotechnologies Inc
Glyphic Biotechnologies Inc Miscellaneous Commercial ServicesCommercial Services Glyphic Biotechnologies Inc is an American biotechnology company that develops a protein sequencing platform to provide researchers with new insights into biology and disease. Glyphic Biotechnologies was founded by Joshua Yang and Daniel Estandian, with Joshua Yang serving as the CEO since incorporation. | Commercial Services |
- Stock Market
- Insiders
- Joshua Yang
- Experience
